PATH MER Indicators
0.1.0 - STU1
PATH MER Indicators
0.1.0 - STU1
PATH MER Indicators, published by PATH. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/PATH-Global-Health/MERindicators and changes regularly. See the Directory of published versions
| Draft as of 2023-10-19 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="DAKARTMeds"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="CodeSystem-DAKICD11.html"><code>http://hl7.org/fhir/sid/icd-11</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM35P4">XM35P4</a></td><td>Abacavir</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM2L06">XM2L06</a></td><td>Emtricitabine</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM5471">XM5471</a></td><td>Lamivudine</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM9C07">XM9C07</a></td><td>Zidovudine</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM8Z78">XM8Z78</a></td><td>Didanosine</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM7RM1">XM7RM1</a></td><td>Stavudine</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM67N3">XM67N3</a></td><td>Tenofovir disoproxil</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM1DX2">XM1DX2</a></td><td>Efavirenz</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM7N44">XM7N44</a></td><td>Etravirine</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM10T5">XM10T5</a></td><td>Nevirapine</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM1KD4">XM1KD4</a></td><td>Rilpivirine</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM4TF3">XM4TF3</a></td><td>Atazanavir and Ritonavir</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM3EH7">XM3EH7</a></td><td>Lopinavir and Ritonavir</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM8ZN1">XM8ZN1</a></td><td>Darunavir and Ritonavir</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM56L1">XM56L1</a></td><td>Ritonavir</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM6K45">XM6K45</a></td><td>Dolutegravir</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM82D3">XM82D3</a></td><td>Raltegravir</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM8QY9">XM8QY9</a></td><td>Lamivudine, Tenofovir disoproxil and Dolutegravir</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM3U67">XM3U67</a></td><td>Antivirals for treatment of human immunodeficiency virus infections, combinations best fit</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM9NL2">XM9NL2</a></td><td>Lamivudine, Tenofovir disoproxil and Efavirenz</td></tr><tr><td><a href="CodeSystem-DAKICD11.html#DAKICD11-XM2UU9">XM2UU9</a></td><td>Lamivudine, Abacavir and Dolutegravir</td></tr></table></li><li>Include these codes as defined in <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="http://snomed.info/id/387005008">387005008</a></td><td>Abacavir (substance)</td></tr><tr><td><a href="http://snomed.info/id/404856006">404856006</a></td><td>Emtricitabine (substance)</td></tr><tr><td><a href="http://snomed.info/id/386897000">386897000</a></td><td>Lamivudine (substance)</td></tr><tr><td><a href="http://snomed.info/id/387151007">387151007</a></td><td>Zidovudine (substance)</td></tr><tr><td><a href="http://snomed.info/id/387105006">387105006</a></td><td>Didanosine (substance)</td></tr><tr><td><a href="http://snomed.info/id/386895008">386895008</a></td><td>Stavudine (substance)</td></tr><tr><td><a href="http://snomed.info/id/422091007">422091007</a></td><td>Tenofovir (substance)</td></tr><tr><td><a href="http://snomed.info/id/387001004">387001004</a></td><td>Efavirenz (substance)</td></tr><tr><td><a href="http://snomed.info/id/432121008">432121008</a></td><td>Etravirine (substance)</td></tr><tr><td><a href="http://snomed.info/id/386898005">386898005</a></td><td>Nevirapine (substance)</td></tr><tr><td><a href="http://snomed.info/id/703123005">703123005</a></td><td>Rilpivirine (substance)</td></tr><tr><td><a href="http://snomed.info/id/427314002">427314002</a></td><td>Antiviral therapy (procedure)</td></tr><tr><td><a href="http://snomed.info/id/776569000">776569000</a></td><td>Product containing only lopinavir and ritonavir (medicinal product)</td></tr><tr><td><a href="http://snomed.info/id/386896009">386896009</a></td><td>Ritonavir (substance)</td></tr><tr><td><a href="http://snomed.info/id/713464000">713464000</a></td><td>Dolutegravir (substance)</td></tr><tr><td><a href="http://snomed.info/id/429707008">429707008</a></td><td>Raltegravir (substance)</td></tr><tr><td><a href="http://snomed.info/id/708255002">708255002</a></td><td>First-line treatment (procedure)</td></tr><tr><td><a href="http://snomed.info/id/708256001">708256001</a></td><td>Second-line treatment (procedure)</td></tr></table></li></ul></div>
</text>
<url
value="https://path-global-health.github.io/MERindicators/ValueSet/DAKARTMeds"/>
<version value="0.1.0"/>
<name value="DAKARTMeds"/>
<title value="ART medications"/>
<status value="draft"/>
<experimental value="false"/>
<date value="2023-10-19T20:59:19+00:00"/>
<publisher value="PATH"/>
<contact>
<name value="PATH"/>
<telecom>
<system value="url"/>
<value value="https://www.path.org"/>
</telecom>
<telecom>
<system value="email"/>
<value value="info@path.org"/>
</telecom>
</contact>
<contact>
<name value="PATH"/>
<telecom>
<system value="email"/>
<value value="info@path.org"/>
<use value="work"/>
</telecom>
</contact>
<description value="ART medications from the HIV DAK"/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://hl7.org/fhir/sid/icd-11"/>
<concept>
<code value="XM35P4"/>
<display value="Abacavir"/>
</concept>
<concept>
<code value="XM2L06"/>
<display value="Emtricitabine"/>
</concept>
<concept>
<code value="XM5471"/>
<display value="Lamivudine"/>
</concept>
<concept>
<code value="XM9C07"/>
<display value="Zidovudine"/>
</concept>
<concept>
<code value="XM8Z78"/>
<display value="Didanosine"/>
</concept>
<concept>
<code value="XM7RM1"/>
<display value="Stavudine"/>
</concept>
<concept>
<code value="XM67N3"/>
<display value="Tenofovir disoproxil"/>
</concept>
<concept>
<code value="XM1DX2"/>
<display value="Efavirenz"/>
</concept>
<concept>
<code value="XM7N44"/>
<display value="Etravirine"/>
</concept>
<concept>
<code value="XM10T5"/>
<display value="Nevirapine"/>
</concept>
<concept>
<code value="XM1KD4"/>
<display value="Rilpivirine"/>
</concept>
<concept>
<code value="XM4TF3"/>
<display value="Atazanavir and Ritonavir"/>
</concept>
<concept>
<code value="XM3EH7"/>
<display value="Lopinavir and Ritonavir"/>
</concept>
<concept>
<code value="XM8ZN1"/>
<display value="Darunavir and Ritonavir"/>
</concept>
<concept>
<code value="XM56L1"/>
<display value="Ritonavir"/>
</concept>
<concept>
<code value="XM6K45"/>
<display value="Dolutegravir"/>
</concept>
<concept>
<code value="XM82D3"/>
<display value="Raltegravir"/>
</concept>
<concept>
<code value="XM8QY9"/>
<display value="Lamivudine, Tenofovir disoproxil and Dolutegravir"/>
</concept>
<concept>
<code value="XM3U67"/>
<display
value="Antivirals for treatment of human immunodeficiency virus infections, combinations best fit"/>
</concept>
<concept>
<code value="XM9NL2"/>
<display value="Lamivudine, Tenofovir disoproxil and Efavirenz"/>
</concept>
<concept>
<code value="XM2UU9"/>
<display value="Lamivudine, Abacavir and Dolutegravir"/>
</concept>
</include>
<include>
<system value="http://snomed.info/sct"/>
<concept>
<code value="387005008"/>
<display value="Abacavir (substance)"/>
</concept>
<concept>
<code value="404856006"/>
<display value="Emtricitabine (substance)"/>
</concept>
<concept>
<code value="386897000"/>
<display value="Lamivudine (substance)"/>
</concept>
<concept>
<code value="387151007"/>
<display value="Zidovudine (substance)"/>
</concept>
<concept>
<code value="387105006"/>
<display value="Didanosine (substance)"/>
</concept>
<concept>
<code value="386895008"/>
<display value="Stavudine (substance)"/>
</concept>
<concept>
<code value="422091007"/>
<display value="Tenofovir (substance)"/>
</concept>
<concept>
<code value="387001004"/>
<display value="Efavirenz (substance)"/>
</concept>
<concept>
<code value="432121008"/>
<display value="Etravirine (substance)"/>
</concept>
<concept>
<code value="386898005"/>
<display value="Nevirapine (substance)"/>
</concept>
<concept>
<code value="703123005"/>
<display value="Rilpivirine (substance)"/>
</concept>
<concept>
<code value="427314002"/>
<display value="Antiviral therapy (procedure)"/>
</concept>
<concept>
<code value="776569000"/>
<display
value="Product containing only lopinavir and ritonavir (medicinal product)"/>
</concept>
<concept>
<code value="386896009"/>
<display value="Ritonavir (substance)"/>
</concept>
<concept>
<code value="713464000"/>
<display value="Dolutegravir (substance)"/>
</concept>
<concept>
<code value="429707008"/>
<display value="Raltegravir (substance)"/>
</concept>
<concept>
<code value="708255002"/>
<display value="First-line treatment (procedure)"/>
</concept>
<concept>
<code value="708256001"/>
<display value="Second-line treatment (procedure)"/>
</concept>
</include>
</compose>
</ValueSet>
IG © 2023+ PATH. Package path.merindicators#0.1.0 based on FHIR 4.0.1. Generated 2023-10-19
Links: Table of Contents |
QA Report |
Version History |
|